Hosted on MSN16d
MediWound announces Phase III CIDS publication on NexoBridThese results reinforce NexoBrid’s clinical benefits as a rapid, effective, and non-surgical alternative for eschar removal in pediatric burn patients, validating its significance as a ...
MediWound (MDWD) announced the publication of its Phase III Children Innovative Debridement Study in Burns, the peer-reviewed Journal of the ...
Findings in Burns Journal confirm NexoBrid’s superiority over standard of care in pediatric patients with deep thermal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results